Researchers Uncover Cellular Mechanism Responsible for Chronic Inflammation, Type 2 Diabetes
Researchers from Boston University School of Medicine (BUSM) have demonstrated that certain T cells require input from monocytes in order to maintain their pro-inflammatory response in people with type 2 diabetes (T2D). The study also showed, for the first time, how a loss in homeostasis in this group of T cells most likely promotes chronic inflammation associated with T2D.
Higher Heart Disease and Diabetes Risk for 3 Million U.S. Kids
A Wake Forest study found that the children showed early signs of heart disease and diabetes, with the differences most notable in boys. More than...
Type 2 diabetics: Insulin and Other Medications May Do More Harm Than Good
For type 2 diabetics - especially those over age 50 - the negative impact of side effects like weight gain and burdens like frequent insulin shots trumps the benefits of drugs.
Vitamins C and E May Enhance Effectiveness of Insulin for Diabetes
Adding antioxidants to therapy improves drug's ability to reduce blood sugar.
Research Offers Potential for New Diabetes Diagnostic Test
The death of insulin-producing beta cells in the pancreas is a core defect in diabetes. Scientists in Italy and Texas now have discovered a new way that these cells die - by toxic imbalance of a molecule secreted by other pancreatic cells.
Eye Study Finds 2 Therapies Slow Diabetic Eye Disease Progression
In high-risk adults with type 2 diabetes, researchers have found that two therapies may slow the progression of diabetic retinopathy, an eye disease that is the leading cause of vision loss in working-age Americans.
Most Primary Physicians Can’t Identify All Prediabetes Risk Factors
Study findings may be a wake-up call for primary care providers, the majority of which could not identify all 11 risk factors that qualify patients for prediabetes screening.
Study Finds New Evidence of Periodontal Disease Leading to Gestational Diabetes
A new study has uncovered evidence that pregnant women with periodontal (gum) disease face an increased risk of developing gestational diabetes even if they don't smoke or drink.
Twin Study: Getting Diabetes Before 65 More Than Doubles Risk For Alzheimer’s Disease
Diabetics have a significantly greater risk of dementia, both Alzheimer's disease - the most common form of dementia - and other dementia, reveals important new data from an ongoing study of twins. The risk of dementia is especially strong if the onset of diabetes occurs in middle age.
Diabetic Eye Disease More Severe in African-Americans Who Consume More Calories, Sodium
High intakes of calories and sodium appear to be associated with the progression of retinal disease among African American patients with diabetes.
Traditional Laser Treatment More Effective than New Drug Therapy for Preserving Eyesight in Diabetic...
Five years ago, ophthalmologists started using steroid injections as a new way of treating diabetics with swelling in their eyes. Now, research shows that the traditional treatment for this disorder is still more effective.
Melatonin Receptor Gene Mutations Lead to an Increased Risk of Developing Diabetes
Researchers demonstrated that mutations in the melatonin receptor gene (melatonin or the "hormone of darkness" induces sleep) lead to an almost sevenfold increase in the risk of developing diabetes.
Evidence that Sugar has a Direct Effect on Risk Factors for Heart Disease and...
Researchers have uncovered evidence that sugar has a direct effect on risk factors for heart disease, and is likely to impact on blood pressure, independent of weight gain.
Diabetes Duration and Severity Associated with Brain Atrophy
Type 2 diabetes may be associated with brain degeneration, according to a new multicenter study.
Immune System Discovery May Lead To Preventive Therapy For Diabetes
By manipulating a cell that controls the immune system’s response to infections, researchers at Dana-Farber Cancer Institute and their colleague have prevented the onset of diabetes in mice predisposed to the disease.
FDA Approves Lucentis to Treat Diabetic Macular Edema
The U.S. Food and Drug Administration today approved Lucentis (ranibizumab injection) for the treatment of diabetic macular edema (DME), a sight-threatening eye disease that occurs in people with diabetes.